Navigation Links
Ampio Awarded US and Canadian Patents that will Bolster the Commercialization of Optina™ for the treatment of Diabetic Macular Edema (DME)
Date:4/27/2012

GREENWOOD VILLAGE, Colo., April 27, 2012 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (Nasdaq: AMPE), a biopharmaceutical company conducting clinical trials on its three lead drugs (Ampion™, Optina™ and Zertane™), licensing distribution of these drugs and developing additional new drugs, today announced that it received notice of allowance of a patent from the US office of patents and trademarks for its DME drug Optina™. Ampio also received a notice of allowance of a similar patent from the Canadian Intellectual Property Office. These initial patents cover the North American territories and multiple additional patents for using Optina™ for the treatment of macular edema and diabetic retinopathy are pending worldwide.

According to Michael Macaluso, Ampio's CEO, "Optina™ is an ultra-low oral (capsule), not commercially available, dose of danazol for the treatment of DME. To our knowledge, no other oral drug to treat this condition exists and there is currently no drug approved by the FDA for this condition. The allowance of these patents in North America is an important step in the development and commercialization of this novel drug as they include multiple claims for the beneficial effects of ultra-low dose Optina™ on vascular hyperpermeability encountered in DME and other vascular leakage syndromes. These patents have an unusually long patent life that expires in 2030. In contrast, most drugs at this stage of development (just before a pivotal trial) have exhausted a large portion of their patent life. These patent claims provide especially strong protection because of the unexpected finding of efficacy only at the very low doses. Ampio is currently in discussions with potential partners to co-develop Optina™ for DME."

Dr. David Bar-Or, Chief Scientific Officer for Ampio, explained, "The mode of action of Optin
'/>"/>

SOURCE Ampio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Ampio Strengthens Patent Protection for Lead Drug Ampion™
2. Ampio Announces Positive Preliminary Update on the Optina™ Clinical Trial to Treat Diabetic Macular Edema and Decision to Conclude the Study Ahead of Schedule
3. Champions Oncology Reports Fiscal 2012 Third Quarter Financial Results
4. Ampio Pharmaceuticals Reports Full-Year 2011 Financial Results and Milestone Highlights for 2011
5. Ampio Pharmaceuticals Schedules 2012 Outlook Webcast
6. Executive Changes at Ampio
7. Ampio Pharmaceuticals Schedules Webcast to Update Shareholders
8. Ampio Pharmaceuticals Announces Registered Direct Common Stock Offering of Approximately $9.436 Million
9. Ampio Responds to Recent Publications by Anonymous Short Sellers
10. Champions Oncology Reports Fiscal 2012 Second Quarter Financial Results
11. FDA Advisory Panel Recommends Against Approval of Champion® Heart Failure Management System for Patients With Heart Failure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... The Pharmaceutical Care Management Association (PCMA) ... D offsets included in the Energy & Commerce ... the 21st Century Cures initiative can only be advanced ... – Medicare – then its costs outweigh any ... "Leveraging payments to Part D plans ...
(Date:5/21/2015)... 21, 2015 ... Zwecks Leistungsvergleich zur Expertise und zum ... verwiesen, in denen uneingeschränkt betriebsfähige Systeme, ... ein Aegate-Land: beispielsweise BELGIEN   ... von Arzneimittelfälschungen (FMD) handelt es sich ...
(Date:5/21/2015)... May 21, 2015 In praising today,s ... legislation by the House Energy and Commerce Committee, ... Committee for recognizing the unique challenges facing long-term ... including bill language exempting Part D beneficiaries in ... proposed medication management "lock-in" provision. The SCPC has ...
Breaking Medicine Technology:EU-Arzneimittel-Richtlinie für gefälschte Medikamente; Aegate-Zusammenfassung als reale Bewertung aus Belgien 2EU-Arzneimittel-Richtlinie für gefälschte Medikamente; Aegate-Zusammenfassung als reale Bewertung aus Belgien 3SCPC Applauds Unanimous House Panel Passage of 21st Century Cures Bill Recognizing Unique Challenges Facing Long Term Care (LTC) Pharmacy Patients, Providers 2
... Colo. , Feb. 11 Mesa Laboratories, Inc. (Nasdaq: ... quarter and nine months ended December 31, 2009 . , ... Testing product line completed. Nine month cash flow provided ... 16% in the most recent six month period over the prior six ...
... , , ... Today, Siemens Healthcare announced it has renewed its ... innovative ambulatory information technology (IT) solutions. More than 35 ... tools throughout their physician networks as a result of ...
Cached Medicine Technology:Mesa Labs Reports Quarterly Sales and Earnings 2Mesa Labs Reports Quarterly Sales and Earnings 3Mesa Labs Reports Quarterly Sales and Earnings 4Mesa Labs Reports Quarterly Sales and Earnings 5Mesa Labs Reports Quarterly Sales and Earnings 6Siemens and NextGen Healthcare Renew Alliance To Deliver Ambulatory IT Solutions 2Siemens and NextGen Healthcare Renew Alliance To Deliver Ambulatory IT Solutions 3Siemens and NextGen Healthcare Renew Alliance To Deliver Ambulatory IT Solutions 4
(Date:5/22/2015)... May 22, 2015 Carnegie Science ... today announced a new partnership to develop BodyTech, a ... region. The initiative includes a new exhibit at the ... demonstration theater, and a new traveling science show, Anatomy ... of 2015. , Designed to explore a wide ...
(Date:5/22/2015)... According to a new Aegis Living Study on Attitudes ... to worry about what will happen to their memory as ... Silent Generation), which may help explain why nearly half of ... Millennials (47%), Gen X’ers (51%), and Boomers (43%). The study ... more than 2,000 U.S. adults ages 18+. , “This ...
(Date:5/22/2015)... McClean, Virginia (PRWEB) May 22, 2015 ... provider of Health IT solutions, announced today that ... ZH Healthcare is the developer of BlueEHS,a first ... (EHS). BlueEHS offers a customizable Electronic Health Records ... e-Rx, lab interfaces, a telemedicine-enabled comprehensive patient portal, ...
(Date:5/22/2015)... Gateway Building Concepts is experienced with ... the company specialize in include decks, additions, kitchen remodeling, ... and much more. , The redesigned logo is ... the company. It includes two geometrical lines that represent ... out to be used with many things associated with ...
(Date:5/22/2015)... 22, 2015 A Phase 3 ... American Society of Clinical Oncology (ASCO)’s annual meeting ... rates for those patients who received bevacizumab in ... pemetrexed/cisplatin. Bevacizumab (Avastin® Genentech, Inc.) is an antibody ... is already routinely used to treat many other ...
Breaking Medicine News(10 mins):Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 2Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 3Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 4Health News:New Study Reveals America’s Fear of Aging 2Health News:New Study Reveals America’s Fear of Aging 3Health News:ZH Healthcare Adds Bill Lane to Advisory Board 2Health News:Mesothelioma Research Organization Excited About Imminent Improvement to Standard of Care 2
... ... Same Commitment to ... the Health of all Babies, CINCINNATI, Feb. 12 ... 4-year-old Bradley,Coffey of Kennedy Heights and his family will serve as the ... for Babies is the March of Dimes premier fundraising event that,benefits all ...
... be done to help people living near major flight hubs, ... People who live near major airports may be disturbed by ... new study finds it can also boost their blood pressure ... noise, the higher blood pressure will go, the study found. ...
... Clinton, Obama, McCain, Huckabee to,Further Discuss, Outline Long ... As Democratic,presidential candidate Hillary Clinton begins her ... increasingly important March 4 Texas,primaries, the Texas Health ... both parties to go beyond the discussion of,increasing ...
... Lifesciences,Corporation (NYSE: EW ), the world leader in ... filed a patent infringement lawsuit against,CoreValve, Inc., of Irvine, ... of Delaware. The suit seeks injunctive relief and damages ... for transcatheter,heart valve technology., "Edwards has a significant ...
... 12 Ehmke,Manufacturing Company of Philadelphia was ... Agency honored 23 industry partners, customers and,individuals ... Ehmke received the Innovative Business Performer ... business (HUB) zone, small business,category. The award ...
... AOPO Coordinate Briefing on Feb. 12, ... who play a significant role in preparing ... of key,transplantation groups. The American Society of ... Network for Organ Sharing (UNOS),and Association of ...
Cached Medicine News:Health News:Local Families Chosen for Ambassador Role for 2008 March for Babies 2Health News:Local Families Chosen for Ambassador Role for 2008 March for Babies 3Health News:Airplane Noise Boosts Blood Pressure Even During Sleep 2Health News:Airplane Noise Boosts Blood Pressure Even During Sleep 3Health News:Growing Importance of March 4 Texas Primary Requires 2008 Presidential Candidates to Better Address Eldercare Financing Issues 2Health News:Edwards Lifesciences Initiates Patent Infringement Litigation Against CoreValve in the U.S. 2Health News:Defense Logistics Agency Recognizes Ehmke Manufacturing Company 2Health News:Transplant Community Unites to Educate Capitol Hill Staffers About the 'Gift of Life' 2
... Centuries of German Craftsmanship have ... in the world. Ocutek now ... Only holders of the coveted ... eight-year apprenticeship, are qualified to ...
1mm by 7mm horizontal punch. Flat serrated handle. Overall length 87mm....
Vertical punch designed to create a 1.5mm clean cylindrical hole. Rotatable for convenient positioning. Flat Handle. Overall length 87mm....
... integrated neck. Piston assembly fits into ... spring to recoil back to ready ... into precision milled cavity in platform. ... - 9.0mm. Designed for the preparation ...
Medicine Products: